A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD (VIVA-MIND)
A Phase 2A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Varoglutamstat (PQ912) in Patients With Early Alzheimer's Disease With a Stage-Gate to Phase 2B (VIVA-MIND)
Sponsor: Alzheimer's Disease Cooperative Study (ADCS)
Terminated
It has been made the strategic decision to terminate the study. This decision to terminate the study early is not being made for safety reasons.
A PHASE2 clinical study on Alzheimer Disease, this trial is terminated or withdrawn. The trial is conducted by Alzheimer's Disease Cooperative Study (ADCS) and has accumulated 32 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
32 versions recorded-
Jan 2026 — Present [monthly]
Terminated PHASE2
-
Sep 2025 — Jan 2026 [monthly]
Terminated PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Terminated PHASE2
-
Sep 2024 — Aug 2025 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
▶ Show 27 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE2
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Dec 2023 — May 2024 [monthly]
Recruiting PHASE2
-
Nov 2023 — Dec 2023 [monthly]
Recruiting PHASE2
-
Sep 2023 — Nov 2023 [monthly]
Recruiting PHASE2
-
Aug 2023 — Sep 2023 [monthly]
Recruiting PHASE2
-
Apr 2023 — Aug 2023 [monthly]
Recruiting PHASE2
-
Feb 2023 — Apr 2023 [monthly]
Recruiting PHASE2
-
Dec 2022 — Feb 2023 [monthly]
Recruiting PHASE2
-
Jul 2022 — Dec 2022 [monthly]
Recruiting PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jan 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jul 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2019 — Apr 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE2
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alzheimer's Disease Cooperative Study (ADCS)
- National Institute on Aging (NIA)
- Vivoryon Therapeutics N.V.
For direct contact, visit the study record on ClinicalTrials.gov .